跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Afreplatin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Afreplatin
Approved
STANDARD
Afreplatin
Venus Remedies Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
477a0105397fc0f2
Company
Venus Remedies Limited
Type
Standard
Approval Details
Approval Id
477a0105397fc0f2
Drug Approval Philippines Name
Afreplatin
Product Name
Afreplatin
Registration Number
DRP-9114-01
Brand Name
Afreplatin
Generic Name
Carboplatin
Dosage Form
Solution For Intravenous Infusion
Dosage Strength
10mg/mL (450mg/45mL)
Manufacturer
Venus Remedies Limited
Importer
Bliss Pharma Distribution and Consultancy Corp.
Distributor
Afree Pharmaceutical Distribution Corp
Company Detail Path
/organization/venus-remedies-limited
Issuance Date
24 January 2022
Expiry Date
06 October 2025
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
477a0105397fc0f2
Type
Standard
Back to Philippines FDA Approvals